Kaka'ako Research
Advancing high-quality healthcare assets through critical transitions
Kaka'ako Research is a healthcare asset development firm that works with therapeutic and diagnostic programs navigating operational, organizational, or partnering transitions as they move toward their next value inflection point.
We collaborate with asset owners, scientific teams, and partners to help promising programs progress efficiently and responsibly.
What We Do
Program Advancement
We engage with therapeutic and diagnostic programs that have strong scientific foundations but require refinement in development strategy, organizational structure, or business alignment to progress to their next stage.
Translational Development
Operating as a translational development group, we support development planning, positioning, and execution to align scientific progress with regulatory, clinical, and commercial pathways.
Partnering & Transition
Programs are advanced toward licensing, spin-out, or strategic partnership with organizations best positioned to support long-term development.
Why We Exist
As scientific programs mature, they often encounter execution and alignment challenges that are not scientific in nature. These challenges can emerge from changes in organizational focus, resource availability, or market context.
Kaka'ako Research exists to provide focused development and partnering support at these transition points, enabling high-quality programs to move forward without unnecessary delay or loss of value.
Our Approach
We engage selectively and collaboratively, tailoring our involvement to the needs of each program and its stakeholders.
Programs we work with often exhibit:
- Strong scientific data and validation in relevant models
- A clear unmet medical or clinical opportunity
- Development or commercialization pathways that require refinement or re-alignment
- Capitalization, operational, or partnering structures that are no longer optimal for the next phase
Our role is complementary and transitional, not corrective.
We are not:
- A general accelerator or incubator
- A CRO
- A passive capital provider
- A long-term owner of operating companies
Area of Focus
Our work spans therapeutics and applied AI in healthcare, with discipline around readiness and pathway to impact.
Areas of focus include:
- Small-molecule and biologic therapeutics
- Platform and asset-centric biotech programs
- AI-enabled diagnostic and decision-support tools
- Translational academic and early-industry programs
Specific programs and partnerships are confidential.
Team
Kaka'ako Research is led by experienced drug development entrepreneurs with a track record of building companies, advancing therapeutic programs, and executing partnerships across the healthcare ecosystem.
Advisory Network
Kaka'ako Research engages a network of scientific, clinical, regulatory, and business development advisors tailored to the specific needs of each program. This includes specialists in medicinal chemistry, preclinical development, regulatory strategy, and partnering execution across therapeutic areas and development stages.
© 2026 Kaka'ako Research. All rights reserved.